12:00 AM
 | 
May 18, 2009
 |  BC Week In Review  |  Company News  |  Deals

EMO-FARM, Valeant Pharmaceuticals International deal

Valeant acquired dermatology company EMO-FARM for $28 million in cash. EMO-FARM markets a number of products including naproxen analgesic and anti-inflammatory gel and Emorect...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >